AAKAAR — Aakaar Medical Technologies Income Statement
0.000.00%
- IN₹1.33bn
- IN₹1.48bn
- IN₹461.11m
Annual income statement for Aakaar Medical Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 195 | 328 | 461 |
Cost of Revenue | |||
Gross Profit | 104 | 178 | 252 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Other Operating Expenses | |||
Total Operating Expenses | 171 | 293 | 412 |
Operating Profit | 23.7 | 34.4 | 48.6 |
Total Net Non Operating Interest Income / Expense | |||
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 22 | 31 | 38.9 |
Provision for Income Taxes | |||
Net Income After Taxes | 16.2 | 21.5 | 28.7 |
Net Income Before Extraordinary Items | |||
Net Income | 16.2 | 21.5 | 28.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 16.2 | 21.5 | 28.7 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 1.14 | 1.52 | 2.03 |